glp-1 new hope in the fight against obesity 🌍💊 The WHO now recommends medications as part of comprehensive treatment—paired with a healthy diet and regular exercise—for meaningful, sustainable weight management. Credit to: Patient transformation story, New Hope

Obesity affects 42% of adults in the United States and is strongly associated with major cardiovascular disease risk factors, including high blood pressure, abnormal cholesterol levels, and insulin resistance, making effective obesity treatment a critical public health priority.

Wondering why semaglutide can make you tired

Hannah Chandler, 35, from California, had tried and failed to lose weight for yearsbut then she discovered a medication that helped her shed 120 pounds in 18 months

Rita Kapoor in Frederick, MD

Discover how once-monthly maridebart cafraglutide for the treatment of obesity works, its clinical trial evidence, potential eligibility criteria, side effects, and the pathway to NHS access if approved by UK regulators.

IntroductionWeight loss is more than just willpower and dieting